Gilead Sciences, Inc. (GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	142,891	115,118	100,942	107,677	91,081	73,031
Market Cap Growth	14.04%	14.04%	-6.25%	18.22%	24.72%	-11.16%
Enterprise Value	158,645	131,586	116,722	125,356	111,060	75,312
Last Close Price	114.74	92.37	77.83	79.41	64.23	49.43
PE Ratio	297.69	239.83	17.82	23.45	14.63	593.74
Forward PE	14.45	12.55	10.88	12.90	10.79	8.59
PS Ratio	4.98	4.00	3.72	3.95	3.34	2.96
PB Ratio	7.40	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	13.87	11.17	13.60	12.90	8.43	9.71
P/OCF Ratio	13.20	10.63	12.61	11.87	8.00	8.94
PEG Ratio	0.51	0.74	0.93	8.42	-	3.04
EV/Sales Ratio	5.52	4.58	4.30	4.59	4.07	3.05
EV/EBITDA Ratio	11.79	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.84	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	15.39	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.42	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	2.01	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.65	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.47	0.47	0.43	0.42	0.40	0.38
Inventory Turnover	3.58	3.58	3.65	3.62	3.35	2.83
Quick Ratio	1.33	1.33	1.15	1.04	1.02	1.20
Current Ratio	1.60	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	2.29%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	11.03%	11.03%	9.25%	10.46%	10.94%	10.53%
Return on Capital (ROIC)	14.07%	14.07%	12.15%	14.38%	15.11%	13.93%
Return on Capital Employed (ROCE)	22.74%	22.74%	18.25%	21.13%	21.18%	19.22%
Earnings Yield	0.34%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	7.21%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	3.37%	3.33%	3.85%	3.68%	4.42%	5.50%
Payout Ratio	1018.42%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	0.24%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	3.61%	3.57%	4.17%	3.76%	4.50%	6.60%

Source: S&P Capital IQ. Standard template. Financial Sources.